文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Cortical laminar binding of PET amyloid and tau tracers in Alzheimer disease.

作者信息

Li Yi, Tsui Wai, Rusinek Henry, Butler Tracy, Mosconi Lisa, Pirraglia Elizabeth, Mozley David, Vallabhajosula Shankar, Harada Ryuichi, Furumoto Shozo, Furukawa Katsutoshi, Arai Hiroyuki, Kudo Yukitsuka, Okamura Nobuyuki, de Leon Mony J

机构信息

Center for Brain Health, New York University, New York, New York Shandong University, Shandong, China.

Center for Brain Health, New York University, New York, New York.

出版信息

J Nucl Med. 2015 Feb;56(2):270-3. doi: 10.2967/jnumed.114.149229. Epub 2015 Jan 8.


DOI:10.2967/jnumed.114.149229
PMID:25572087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4652320/
Abstract

UNLABELLED: Neurofibrillary tau pathology and amyloid β (Aβ) plaques, characteristic lesions of Alzheimer disease (AD), show different neocortical laminar distributions. Neurofibrillary-tangle tau pathology tends to be closer to the gray matter-white matter boundary, whereas Aβ is dispersed throughout the width of the cortical ribbon. METHODS: Using PET radiotracers for tau and Aβ lesions, we developed an image analysis tool to measure the distance of tracer-positive voxels from the gray matter-white matter boundary. We studied 5 AD and 5 healthy subjects with both (18)F-THK5117 (tau) and (11)C-Pittsburgh compound B (Aβ) PET. RESULTS: On average, tau-positive voxels were closer to the white matter than were Aβ-positive voxels. This effect was found for all AD subjects and for all regions, both before and after regionally adjusting for the nonspecific white matter binding of both tracers. The differential laminar pattern was validated through postmortem examination. CONCLUSION: Within cortical lamina, distance measures may be of value in testing PET tracers for their anatomic selectivity.

摘要

相似文献

[1]
Cortical laminar binding of PET amyloid and tau tracers in Alzheimer disease.

J Nucl Med. 2015-2

[2]
Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease.

J Nucl Med. 2013-7-15

[3]
Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.

Semin Nucl Med. 2011-7

[4]
Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.

Neuroimage Clin. 2014-11-27

[5]
In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET.

Am J Geriatr Psychiatry. 2004

[6]
PET of brain amyloid and tau in mild cognitive impairment.

N Engl J Med. 2006-12-21

[7]
18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease.

J Nucl Med. 2016-2

[8]
[F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease.

Eur J Nucl Med Mol Imaging. 2019-6-28

[9]
Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.

Brain. 2014-3-27

[10]
Predicted sequence of cortical tau and amyloid-β deposition in Alzheimer disease spectrum.

Neurobiol Aging. 2018-4-17

引用本文的文献

[1]
Parenchymal CSF fraction is a measure of brain glymphatic clearance and positively associated with amyloid beta deposition on PET.

Alzheimers Dement. 2024-3

[2]
Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade.

Int J Mol Sci. 2022-4-30

[3]
Decreased CSF clearance and increased brain amyloid in Alzheimer's disease.

Fluids Barriers CNS. 2022-3-14

[4]
Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective.

Int J Mol Sci. 2021-11-30

[5]
Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development.

Eur J Nucl Med Mol Imaging. 2020-2

[6]
An one-pot two-step automated synthesis of [18F]T807 injection, its biodistribution in mice and monkeys, and a preliminary study in humans.

PLoS One. 2019-7-1

[7]
Military-related risk factors for dementia.

Alzheimers Dement. 2018-11-8

[8]
Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease.

Alzheimers Dement. 2018-10-10

[9]
The development and validation of tau PET tracers: current status and future directions.

Clin Transl Imaging. 2018

[10]
Quantitative evaluation of tau PET tracers F-THK5351 and F-AV-1451 in Alzheimer's disease with standardized uptake value peak-alignment (SUVP) normalization.

Eur J Nucl Med Mol Imaging. 2018-4-27

本文引用的文献

[1]
Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.

Brain. 2014-3-27

[2]
A 2-process model for neuropathology of Alzheimer's disease.

Neurobiol Aging. 2014-2

[3]
Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808.

J Alzheimers Dis. 2014

[4]
Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease.

J Nucl Med. 2013-7-15

[5]
Resolution modeling in PET imaging: theory, practice, benefits, and pitfalls.

Med Phys. 2013-6

[6]
Chronic traumatic encephalopathy: neurodegeneration following repetitive concussive and subconcussive brain trauma.

Brain Imaging Behav. 2012-6

[7]
Imaging beta-amyloid burden in aging and dementia.

Neurology. 2007-5-15

[8]
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.

Ann Neurol. 2004-3

[9]
Phases of A beta-deposition in the human brain and its relevance for the development of AD.

Neurology. 2002-6-25

[10]
Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease.

J Neuropathol Exp Neurol. 1997-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索